![Hana Malik](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historique de carrière de Hana Malik
Anciens postes connus de Hana Malik
Sociétés | Poste | Début | Fin |
---|---|---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
![]() Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Investor Relations Contact | 01/04/2014 | 01/02/2023 |
Corporate Officer/Principal | 01/04/2014 | 01/02/2023 | |
TIZIANA LIFE SCIENCES LTD | Investor Relations Contact | - | - |
Statistiques
Internationale
Bermudes | 3 |
Opérationnelle
Investor Relations Contact | 2 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
TIZIANA LIFE SCIENCES LTD | Health Technology |
Entreprise privées | 1 |
---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
![]() Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Hana Malik
- Expérience